Nxstage Medical Inc
(NXTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 79,911 | 75,286 | 74,083 | 72,221 | 69,450 |
| Cost of Goods | 49,059 | 46,699 | 46,553 | 43,287 | 41,562 |
| Gross Profit | 30,852 | 28,587 | 27,530 | 28,934 | 27,888 |
| Operating Expenses | 35,384 | 35,560 | 34,734 | 34,010 | 33,028 |
| Operating Income | -4,473 | -6,274 | -6,651 | -4,789 | -4,578 |
| Interest Expense | 215 | 255 | 195 | 198 | 149 |
| Other Income | -6 | -10 | -17 | 23 | -69 |
| Pre-tax Income | -4,694 | -6,539 | -6,863 | -4,964 | -4,796 |
| Income Tax | 280 | 295 | 332 | 346 | 380 |
| Net Income Continuous | -4,974 | -6,834 | -7,195 | -5,310 | -5,176 |
| Minority Interests | -122 | -128 | -82 | -35 | N/A |
| Net Income | $-4,852 | $-6,706 | $-7,113 | $-5,275 | $-5,176 |
| EPS Basic Total Ops | -0.07 | -0.11 | -0.12 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.08 | -0.11 | -0.12 | -0.09 | -0.09 |
| EPS Diluted Total Ops | -0.07 | -0.11 | -0.12 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.08 | -0.11 | -0.12 | -0.09 | -0.09 |
| EBITDA(a) | $2,929 | $678 | $101 | $1,802 | $1,840 |